Iron deficiency and safety of ferric carboxymaltose in patients with acute heart failure. AHF-ID study.
Javier JacobÒscar MiróCarles FerreCarmen Borraz-OrdásGuillermo Llopis-GarcíaRosa ComabellaJosé María Fernández-CañadasAmparo MercadoAlex RosetFernando Richard-EspigaAmparo Valero-DomènechJosé Luis Martínez-GimenoFrancisco Javier Martín-SánchezPere LlorensPablo Berrocal-GilMaría José Pérez-DuráJosé María Álvarez-PérezPilar López-DíezPablo Herrero-PuenteJosep Comín-ColetPublished in: International journal of clinical practice (2020)
There are scarce differences between the presence and the type of ID in patients with AHF. The administration of FCM in patients with ID and AHF is safe.